|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||7.69 - 8.14|
|52 Week Range||4.55 - 19.87|
|PE Ratio (TTM)||52.06|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canopy Growth (WEED) (CGC), the biggest cannabis producer in terms of capacity, released its earnings on August 14. On August 15, Canopy Growth stock rose as much as 30% on news that Constellation Brands (STZ) pumped ~$4 billion into the company. With these positive catalysts, Canopy Growth received target price upgrades from four firms.
NEW YORK, NY / ACCESSWIRE / August 16, 2018 / U.S. markets retreated on Wednesday as ongoing trade concerns and the currency crisis in Turkey continued to take center stage. The Dow Jones Industrial Average ...
On August 14, the overall cannabis sector was in the deep red. The Horizons Marijuana Life Sciences ETF (HMMJ) fell 4.5% during the day, while the Emerging Marijuana Growers Index ETF (HMJR) fell 5.7%. The sell-off in the cannabis sector came amid the ongoing global economic concerns, especially in emerging markets. However, the developed markets were broadly positive with the S&P 500 Index (SPY) up by 64 basis points and the TSE Composite Index up by 49 basis points.
Perennial Inc. (“Perennial”), a subsidiary of DATA Communications Management Corp. (DCM.TO) (“DCM”), and Aphria Inc. (TSX:APH and US OTC:APHQF) (“Aphria”) are pleased to announce they have signed a Letter of Intent to form a joint venture (the “JV”) to collaborate on the development of new products, brands and product categories that will drive the evolution of the Canadian adult-use cannabis market. The JV will be powered by Aphria’s best-in-class cannabis production and Perennial’s industry-leading expertise in strategic brand development. As the cannabis industry expands into new and highly-anticipated product categories, Perennial and Aphria believe that a committed, consumer-centric approach will enable the JV to remain on the leading edge of the cannabis industry.
The incremental decriminalization or legalization of cannabis across the world has fed an expanding international market trading the plant, its extracts and its end products. In the last year, Canada followed Uruguay to become one of just two nations to completely legalize marijuana, and Peru, Mexico and Chile legalized medical cannabis. Experts expect the south to attract global investments.
The company’s losses are similar to those of Aphria (APHQF), Supreme Cannabis (SPRWF), and Aurora Cannabis (ACBFF). The current consensus price target for CannTrust was 14.3 Canadian dollars, which declined from 14.5 Canadian dollars a month ago.
Hydropothecary (HYYDF) has done much better than other cannabis producers (HMMJ) such as Cronos (CRON), Aphria (APHQF), and Aurora Cannabis (ACB) (ACBFF). The stock has returned about 4.9% YTD (year-to-date) as of August 7, and it is one of the few cannabis stocks to be in the positive territory so far this year. Interestingly, more analysts are covering the stock compared to Aurora Cannabis.
Arguably, the two hottest sectors over the past 12 months have been Cannabis and Fintech stocks HENDERSON, NV / ACCESSWIRE / August 9, 2018 / Huge news keeps coming for both sectors, NYSE parent company ...
The Scotts Miracle-Gro Company (SMG) reported its quarterly earnings on July 31. The company beat bottom-line estimates but missed top-line estimates. Find out what Market Realist recommends for Scotts Miracle-Gro and other stocks (HMLSF). The consensus rating on Scotts Miracle-Gro remained unchanged from the last month, which was similar to what we saw for Aphria (APHQF) and Canopy Growth (WEED) (CGC).
For years, Ecuador was a difficult place for mining companies to operate, with restrictive regulations and a government stonewalling new investments...until now. The country is making a major effort to improve investment in the region, and some very promising deposits are finally being explored and mined. Lucky Minerals (LJ) is an undiscovered junior in the region with a promising concession near one of the biggest mineral finds of the last twenty years.
Among the well-known cannabis stocks (SEED-TSE) such as Canopy Growth (WEED) and Aurora Cannabis (ACB) (ACBFF), Aphria (APHQF) has been one of the worst performers with a YTD loss of 52%. The consensus ratings on Aphria also remained unchanged from the last month. Out of the eight analysts, three maintained a “strong buy” recommendation on the stock, and four analysts maintained a “buy” on Aphria.
Cannabis stocks have experienced significant declines since the beginning of this year. With that said, some big names such as Canopy Growth (WEED), Aurora Cannabis (ACB) (ACBFF), and Aphria (APHQF) have made heavy capital investments and are here to stay. In this series, we’ll discuss what analysts think about marijuana stocks (HMMJ) in terms of their ratings and price target.
LEAMINGTON, ON , Aug. 8, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed a Manufacturer's Representative agreement (the "Agreement") with We Grow BC Ltd. ("We Grow"), a Vancouver -based licensed producer of premium cannabis, to become We Grow's exclusive sales representative across Canada . The Agreement adds a second brand of premium B.C.-bud to be sold alongside Aphria's expanding portfolio of adult-use brands, which includes celebrated B.C.-bud from Broken Coast Cannabis, through the Company's coast-to-coast sales distribution network. "Aphria has an unmatched ability to offer a cross- Canada sales and distribution network for adult-use cannabis," said Jakob Ripshtein, Chief Commercial Officer at Aphria.
Five countries -- and five marijuana stocks -- that are important in the expansion of worldwide weed.
Green Acre Capital is targeting C$75 million for its second venture capital fund aimed at the Canadian cannabis space, just a year after kicking off its debut investment pool. Tyler Stuart, managing director of Green Acre, told Real Money that Green Acre Capital Fund II will target a 30% IRR (internal rate of return), or a 3x return within seven years. Thus far, the Toronto- and Calgary-based firm's IRR for the C$25 million Fund I is about 160% on the capital deployed in its first year, he said.
Aphria (APH) (APHQF) reported its fiscal fourth quarter of 2018 earnings on August 1. It more than doubled its sales but reported a net quarterly loss. The quarter ended on May 31.
LEAMINGTON, ON , July 31, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it is has secured $25 million in debt financing from WFCU Credit Union ("WFCU"). This is the second round of debt-financing secured by the Company from WFCU, having previously secured a $25 million five-year loan on May 9, 2017 . "We are delighted to once again have the support of WFCU Credit Union as Aphria continues to execute on its long-term strategic plan," said Vic Neufeld , Chief Executive Officer at Aphria.
Last week was a bad week for the cannabis sector, as many of the major players in the industry saw substantial losses week-over-week. The benchmark Horizons Marijuana Life Sciences ETF (HMMJ) ended the week lower by 1.5%, while the ETFMG Alternative Harvest ETF (MJ) declined by 2.8%.
LEAMINGTON, ON , July 26, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it completed its largest international shipment of cannabis oil to date to Australian medical life science company, Medlab Clinical Limited ("Medlab") (ASX:MDC). The shipment is part of the previously announced agreement between Aphria and Medlab in which Aphria produces and supplies high-yield cannabis extracts for Medlab to be used in a human trial to test the management of intractable pain in oncology patients – the first trial of its kind globally.
LEAMINGTON, ON , July 25, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) will release its fourth quarter results for 2018 on August 1, 2018 . Financial results are expected to be released at approximately 7:00am ET , through SEDAR and on Aphria's website at aphria.ca/investors. A conference call is scheduled for 9:00am ET and will feature a presentation by Aphria executives followed by a question and answer period with analysts.
Canada’s marijuana policy shift was only the catalyst in a much larger movement, and now, one small company is looking to create the foundation for an opportunity on a scale never seen before